BIO 300 Oral Powder Safety and Pharmacokinetics
NCT04650555
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
34
Enrollment
INDUSTRY
Sponsor class
Conditions
Acute Radiation Syndrome
Interventions
DRUG:
BIO 300 Oral Powder
Sponsor
Humanetics Corporation
Collaborators
[object Object]
[object Object]